Literature DB >> 6272120

Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells.

I S Trowbridge, D L Domingo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6272120     DOI： 10.1038/294171a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  57 in total

1.  Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.

Authors:  Fernanda I Staquicini; Michael G Ozawa; Catherine A Moya; Wouter H P Driessen; E Magda Barbu; Hiroyuki Nishimori; Suren Soghomonyan; Leo G Flores; Xiaowen Liang; Vincenzo Paolillo; Mian M Alauddin; James P Basilion; Frank B Furnari; Oliver Bogler; Frederick F Lang; Kenneth D Aldape; Gregory N Fuller; Magnus Höök; Juri G Gelovani; Richard L Sidman; Webster K Cavenee; Renata Pasqualini; Wadih Arap
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

2.  Peptides and proteins as drugs.

Authors:  B L Ferraiolo; L Z Benet
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

Review 3.  Transferrin receptor: its biological significance.

Authors:  W S May; P Cuatrecasas
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

4.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

5.  A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity.

Authors:  W Z Wei; R J Massey; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Species specificity of iron delivery in hybridomas.

Authors:  C R Ill; T Brehm; B K Lydersen; R Hernandez; K G Burnett
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

7.  Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma.

Authors:  A Eisenthal; S A Rosenberg
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

Review 8.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.

Authors:  Celine Callens; Séverine Coulon; Jerome Naudin; Isabelle Radford-Weiss; Nicolas Boissel; Emmanuel Raffoux; Pamella Huey Mei Wang; Saurabh Agarwal; Houda Tamouza; Etienne Paubelle; Vahid Asnafi; Jean-Antoine Ribeil; Philippe Dessen; Danielle Canioni; Olivia Chandesris; Marie Therese Rubio; Carole Beaumont; Marc Benhamou; Hervé Dombret; Elizabeth Macintyre; Renato C Monteiro; Ivan C Moura; Olivier Hermine
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

Review 10.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.